A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I InhibitorsTona M. Gilmer, Michael B. Kastan, Chun-Hsiang Lai et al.|Molecular Cancer Therapeutics|2024Cited by 30
Abstract LB181: First disclosure of XRD-0394, a novel dual ATM/DNA-PK inhibitor, that potently radiosensitizes and potentiates PARP and topoisomerase inhibitorsTona M. Gilmer, Michael B. Kastan, Chun-Hsiang Lai et al.|Cancer Research|2024Cited by 4
Table S2 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I InhibitorsTona M. Gilmer, Michael B. Kastan, Kexiao Guo et al.|Unknown|2024Cited by 0
Figure S7 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I InhibitorsTona M. Gilmer, Michael B. Kastan, Chun-Hsiang Lai et al.|Unknown|2024Cited by 0
Kinase Panel 2 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I InhibitorsTona M. Gilmer, Michael B. Kastan, Chun-Hsiang Lai et al.|Unknown|2024Cited by 0